The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Frontotemporal Dementia — Genetic and Advanced Forms

Heterogeneous neurodegenerative dementia spectrum with frontotemporal lobar degeneration, often presenting with behavioral or language variants in adults under 65; up to 40% of cases are familial, with C9orf72, MAPT, and GRN mutations driving disease and shaping emerging gene-targeted therapies.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Nöroloji department. Book Appointment →

What is Frontotemporal Dementia — Genetic and Advanced Forms?

Frontotemporal dementia (FTD) is a clinically and pathologically heterogeneous neurodegenerative disorder of the frontal and temporal lobes presenting with behavioral variant FTD (bvFTD), nonfluent variant primary progressive aphasia (nfvPPA), semantic variant primary progressive aphasia (svPPA), or FTD with motor neuron disease, typically with onset between 45 and 65 years.

Genetic forms account for approximately 30–40% of FTD, with C9orf72 hexanucleotide repeat expansion (associated with FTD-amyotrophic lateral sclerosis), MAPT mutations (tauopathy with parkinsonism), and GRN mutations (TDP-43 pathology with progranulin haploinsufficiency) as the three most common genes; rarer genes include CHMP2B, VCP, TBK1, FUS, and TARDBP.

Diagnosis combines clinical syndrome characterization, neuropsychology, structural and functional imaging (MRI, FDG-PET, tau-PET in research), CSF biomarkers, and genetic testing in patients with familial pattern or early-onset disease, supporting diagnostic certainty and guiding family counseling and trial enrolment.

Symptoms

Behavioral variant: progressive personality change, disinhibition, apathy, loss of empathy, compulsive behaviors, dietary changes
Nonfluent variant primary progressive aphasia: effortful speech, agrammatism, motor speech difficulty
Semantic variant primary progressive aphasia: loss of word and concept meaning, anomia, surface dyslexia
Motor features in C9orf72 carriers: amyotrophic lateral sclerosis with bulbar or limb-onset weakness
Parkinsonism in MAPT-related FTD with progressive supranuclear palsy or corticobasal-like phenotypes
Family history of dementia, ALS, or psychiatric illness, often with autosomal dominant transmission

Risk Factors

Family history of FTD, amyotrophic lateral sclerosis, or atypical parkinsonism in first-degree relatives
C9orf72 hexanucleotide expansion, especially in northern European populations
MAPT mutations clustered in specific kindreds with autosomal dominant transmission
GRN mutations leading to progranulin haploinsufficiency, often with TDP-43 type A pathology
Age between 45 and 65 years, but earlier onset reported with high penetrance mutations
Behavioral or psychiatric symptoms initially misdiagnosed as primary psychiatric disorders, delaying recognition

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Person under 65 years with progressive personality change, language deficit, or atypical parkinsonism — referral to cognitive neurology and behavioral neurology center
  • Patient with first-degree relative diagnosed with FTD or ALS — genetic counseling and predictive testing in selected cases
  • Suspected FTD with motor neuron disease features (fasciculations, bulbar symptoms) — multidisciplinary motor neuron disease clinic
  • Caregiver burden, behavioral crisis, or safety concerns (driving, finances) — social work, psychiatry, and family support
  • Patient interested in clinical trials of gene-targeted therapy — referral to FTD research center experienced with progranulin or antisense oligonucleotide trials

Treatment Methods

01
Comprehensive multidisciplinary care: cognitive neurology, neuropsychology, speech and language therapy, occupational therapy, social work, and palliative care
02
Behavioral management with structured environment, behavioral plans, and selective serotonin reuptake inhibitors for compulsivity, irritability, or impulsivity
03
Avoidance of cholinesterase inhibitors and memantine, which are not effective in FTD; cautious use of antipsychotics due to extrapyramidal sensitivity
04
Genetic counseling and family planning support including options for predictive testing, preimplantation genetic diagnosis, and risk communication
05
Disease-modifying clinical trials targeting underlying pathology: progranulin replacement therapy in GRN carriers, antisense oligonucleotides for C9orf72, anti-tau therapies for MAPT mutations, and emerging stem cell-based approaches

Which Department to Visit?

You can visit our Nöroloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Nöroloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Headache and Migraine

Nöroloji

What you need to know about headache types, migraine attacks, and triggering factors.

Low Back Pain

Nöroloji

Learn about the most common causes of low back pain, risk factors, and appropriate treatment approaches.

Neck Pain and Cervical Disc Herniation

Nöroloji

Learn about the symptoms and treatment options for cervical disc herniation and problems in the neck region.

Epilepsy

Nöroloji

Accurate information about epilepsy, types of seizures, and recommendations for patients and families.

Parkinson Disease

Nöroloji

Parkinson disease is caused by progressive degeneration of dopaminergic neurons and alpha-synuclein accumulation; well-timed therapy substantially improves function and quality of life.

Alzheimer's Disease and Dementia

Nöroloji

Information about early signs, diagnosis, and the care process for Alzheimer's and other types of dementia.

Multiple Sclerosis (MS)

Nöroloji

What is multiple sclerosis, who is at risk, and which treatments are applied?

Stroke

Nöroloji

What is stroke, what are the FAST signs, and why is emergency intervention critical?

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.